Mild Hyperbaric Oxygen Exposure Enhances Peripheral Circulatory Natural Killer Cells in Healthy Young Women
Keywords: Cancer, Natural Killer Cells, Parasympathetic Activity
Title: Mild Hyperbaric Oxygen Exposure Enhances Peripheral Circulatory Natural Killer Cells in Healthy Young Women
Publisher: MDPI Open Access Journal (Print: Life 2023, 13 (2), 408) (Online: 02/01/2023)
Pressure: 1.4 ATA
Oxygen Concentration: 35-40%
Duration: 70 min
Conclusion: Exposure to mild HBO could increase the numbers of NK cells possibly mediated by parasympathetic activity enhancement in healthy volunteers. Moreover, the exposure does not cause systemic oxidative stress or an inflammatory response, so it could be used as a beneficial protocol for enhancing immunity. Women’s health complications can be prevented by using mild HBO to maintain autonomic nervous system balance. In addition, the use of mild HBO is gaining popularity across a variety of therapeutic fields, including for sports and relaxation purposes, but there has been a lack of evidence to support its usage for healthy women. The results of the current study should help expand the usage of mild HBO for immune purposes.
Read the full study.
Effects of an early intervention with Hyperbaric Oxygen Treatment on arm lymphedema and quality of life after breast cancer—an explorative clinical trial
Keywords: Breast Cancer, Lymphedema
Title: Effects of an early intervention with Hyperbaric Oxygen Treatment on arm lymphedema and quality of life after breast cancer—an explorative clinical trial
Oxygen Concentration: unknown
Sessions: 40 (over 8 weeks)
Results: Out of 50 eligible participants, 20 women accepted participation. Nineteen women initiated and completed treatment and follow-up. None of the objective measures of LE severity showed consistent changes during the study period, but participants reported significant improvements in quality of life (QOL) (physical functioning, fatigue, insomnia and breast and arm symptoms), with improvements peaking at 6-month follow-up.
Conclusion: Participants receiving HBOT experienced improved QOL without consistently significant changes in arm mass, volume or lymphatic drainage. These results call for studies into differential effect in patient sub-groups, and a large-scale, randomized placebo-controlled trial with long-term follow-up to assess the effect of HBOT in patients with soft tissue radiation injuries after breast cancer seems warranted.
Read the full study.
Disclaimer: Statements, testimonials, and services provided by Renewal Care, LLC are not intended to diagnose, treat, cure or prevent any disease or illness. [more]
Nothing on this site is to be construed as medical advice; the authors are not doctors. The testimonials and feedback received are voluntarily provided and do not necessarily represent the views of this company. They have not been evaluated by the Food and Drug Administration and are not intended to be a substitute for professional medical advice, diagnosis or treatment. Any recommendations made by Renewal Care, LLC do not constitute as a medical recommendation and are intended for informational and educational purposes only, and no claims (real or implied) are being made. While studies support the use and effectiveness of the available therapies when used to help an individual facing various medical conditions, individual results may vary and it is the responsibility of the client to do their own personal due diligence; always ask your doctor about all treatment options, including all risks and benefits. Renewal Care, LLC is not a health care provider. Please discuss your personal health, including any options or ideas you may read on the internet (on this site or others) with your personal, qualified health practitioner before making changes to your lifestyle, diet, treatments, therapies or adjusting/discontinuing use of any medication.